🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

This might interest you! 🔴👉Some key steps that can help reduce the chance of severe #SARSCoV2 infection: #InnovationKillsTheVirus #RBDCOV

Our latest article is out! 🥽🥼 Discover how Penta - Child Health Research promotes health equity through inclusive clinical trials, focusing on the importance of including children to achieve widespread immunity. Read the full article🔴👉rbdcov.eu/7-advancing-he… #RBDCOV #InnovationKillsTheVirus

#RBDCOV in Figures 🔬 HH-3 Trial: Focused on the safety and immune response of a booster dose in adolescents aged 12 --18. 🔵200+ Participants 🔵Positive Preliminary Results #InnovationKillsTheVirus

Read the full article by EATG with the #RBDCOV Community Advisory Panel and Penta - Child Health Research How can we engage youth in Research & Development initiatives? 👉eatg.org/blogs/recap-wi…

Designing clinical trials for children and adolescents requires careful consideration of their unique physiological and developmental needs. Penta - Child Health Research key partner, ensures these are prioritised in the #RBDCOV project Read our latest specialized article👉acesse.dev/185HU

Vaccination remains the most effective way to protect from #COVID. 🔴That’s why at #RBDCOV, we are committed to developing inclusive and representative clinical trials. Read more in the article below! 🔽🔽

Who are the experts behind our upcoming #RBDCOV #ScienceCafé☕? Dr. BeaMothe is the principal investigator of the HH-4 clinical trial for the COVID-19 vaccine, which focuses on individuals with immunosuppressive conditions. 🔴Register now to join us! 👉shorturl.at/IlyjE

🧬 L’equip de RBDCOV_EU, un projecte europeu amb participació d'#IrsiCaixa, et convida a parlar sobre #COVID19, assaigs clínics i poblacions vulnerables mentre prenem un cafè! Apunta’t els detalls: 🗓️ 18 nov. 📍 Sala Segarra, Ateneu Barcelonès Inscriu-t'hi 👇docs.google.com/forms/d/e/1FAI…

Only 4 days left until our #ScienceCafé at Ateneu Barcelonès Dr. Pere Soler, Head of the Pediatric Infectious Diseases and Immunodeficiencies Unit at Vall d'Hebron will contribute to the discussion with his expertise in research and clinical care. Register now👉 shorturl.at/Wv4t4

🔴☕Next Monday, the 18th, Joan Tallada will complete our Science Café panel! As a member of the RBDCOV Community Advisory Board (CAP) and an active contributor to the EATG Joan brings valuable community insights to our conversation. Register now!👉 rbdcov.eu/science-cafe-l…

Are #ClinicalTrials equal? No. Today learning the challenges in immunodeficiency patients and pediatric population RBDCOV_EU Veristat, LLC Vall d'Hebron Institut de Recerca

We’re Live at the #ScienceCafé with Pere Soler-Palacín, Beatriz Mothe Pujadas, Joan Tallada and Petra Wuelfroth Join us for the open discussion now! 👇👇 us06web.zoom.us/j/84584104675?…

📣 HAPPENING NOW 📣 Today, part of the EATG team is in Barcelona participating in a RBDCOV_EU Science Cafe focused on fostering inclusion in clinical trials. Joan Tallada, CAP member, is sharing his expertise and community perspective! 🗣️👏 #RBDCOV

🔴Last Tuesday, we held our annual CM #RBDCOV at Palau Macaya. #Inclusivity in clinical trials remains a key aspect of this project. We discussed the ethical and technical barriers encountered and agreed on the importance of increasing visibility within the scientific community.

From the RBDCOV team, we wish you a happy and healthy New Year! 🌟 In 2025, we will continue working toward a more inclusive and representative healthcare system👩‍🔬🔴 #RBDCOV #HappyNewYear #Inclusivity #ClinicalTrials

What does the #OneHealth approach mean, and how is #RBDCOV contributing to it?🥼🌏 Preventing and managing threats at their source, promoting a balanced and sustainable response to global challenges that impact all forms of life. 👉Read the full article: rbdcov.eu/the-one-health…

🔍 New ReCAP interview! We're talking accessibility in clinical trials & EU projects with Mona Sundnes & Jenny Camaradou, Members of the RBDCOV_EU Community Advisory Panel. How can we make research more inclusive? Read their insights here ⬇️ 🔗eatg.org/blogs/recap-wi…